ALS (motor neurone disease): open trials in France

13 open trials have a site in France. Registry data; only the trial team decides who can take part.

NCT07322003
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Trial Treatment · Phase 3 · Prilenia
CHU Lille, Lille · Hôpitaux Universitaires de Marseille Timone, Marseille · Centre Hospitalier Universitaire de Nice, Nice · Hospitalier Pitie-Salpetriere, Paris · Centre hospitalier régional universitaire de de Tours, Tours
Registry updated 2026-10-27
NCT07023835
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Trial Treatment · Phase 2 · Zydus Therapeutics Inc.
University Hospital Of Clermont-Ferrand, Clermont Ferrand Cedex 1 · Centre Hospitalier Et Universitaire De Limoges, Limoges Cedex 1 · Centre Hospitalier Universitaire De Montpellier, Montpellier Cedex 5 · Centre Hospitalier Universitaire de Nice, Nice · Assistance Publique Hopitaux de Paris, Paris · Centre Hospitalier Regional Universitaire De Tours, Tours Cedex 9
Registry updated 2026-09-01
NCT06284161
QCT in ALS Diagnosis, Mechanistic Understanding and Follow-up
Trial Treatment · University Hospital, Clermont-Ferrand
CHU de Clermont-Ferrand, Clermont-Ferrand
Registry updated 2026-07-30
NCT07737977
Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients
Research · University Hospital, Montpellier
Montpellier University Hospital, Montpellier
Registry updated 2026-07-30
NCT07698496
Evaluation of the Feasibility and Efficacy of a Chronic Brain-computer Interface for Speech Rehabilitation in Patients With Locked-in-syndrome (LIS)
Trial Treatment · University Hospital, Grenoble
Hôpital Raymond Poincaré Garches, Garches · Centre hospitalier Grenoble, Grenoble · Centre hospitalier Nimes, Nîmes · Centre hospitalier saint Etienne, Saint-Etienne
Registry updated 2026-07-13
NCT07213440
Identification of Early Markers for ALS
Trial Treatment · Institut National de la Santé Et de la Recherche Médicale, France
CHU Tours, Tours
Registry updated 2026-07-07
2025-524002-16-00
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)
Trial Treatment · Phase 3 · Ferrer Internacional S.A.
Centre Hospitalier Universitaire De Lille, Lille Cedex · Centre Hospitalier Regional De Marseille, Marseille · Centre Hospitalier Universitaire de Nice, Nice · Assistance Publique Hopitaux de Paris, Paris · Centre Hospitalier Régional Universitaire de Tours, Tours
Registry updated 2026-05-14
NCT07479017
Characterization of Platelet Molecular Profiles in ALS for the Identification of Specific Diagnostic Biomarkers - A Pilot Study
Research · University Hospital, Tours
University Hospital, Limoges, Limoges · University hospital, Lyon, Lyon · university hospital, Tours, Tours
Registry updated 2026-03-18
NCT04816227
Expression Profile Study of Macrophages From Patients Affected by ALS or Other Related Motor Impairments
Research · Institut National de la Santé Et de la Recherche Médicale, France
Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris
Registry updated 2026-03-09
NCT06249412
The Importance of Positive Expiratory Pressure Associated With the In-exsufflator in ALS Patients
Trial Treatment · Groupe Hospitalier du Havre
GH Havre, Le Havre
Registry updated 2026-01-21
NCT07091799
Interest of Measuring P2X4 Receptors on Blood Monocytes as a Diagnostic Marker in Amyotrophic Lateral Sclerosis: P2X4 as a Diagnostic Biomarker for ALS
Trial Treatment · University Hospital, Bordeaux
Hopital Pellegrin, Bordeaux
Registry updated 2026-01-21
NCT07334743
Identifying Biomarkers in ALS Patients Using Neuronal Derived Extracellular Vesicles
Research · Fondation Ophtalmologique Adolphe de Rothschild
Hopital Fondation Adolphe de Rothschild, Paris
Registry updated 2026-01-12
NCT03127267
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Trial Treatment · Phase 3 · AB Science
CHU de Angers, Angers · Groupe Hospitalier Pellegrin Tripode, Bordeaux · Hôpital Neurologique Pierre Wertheimer, Bron · Chu Gabriel Montpied, Clermont-Ferrand · CHU De Lille, Hôpital Roger Salengro, Lille · CHU de Limoges-Hopital Dupuytren, Limoges · CHU de Marseille - Hôpital de la Timone, Marseille · CHRU de Montpellier - Gui de Chauliac, Montpellier · CHU de Nancy -Hôpital Central, Nancy · CHU Hôpital Pasteur Nice, Nice · CHRU de Tours- Hopital Bretonneau, Tours
Registry updated 2025-09-12

All ALS (motor neurone disease) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error